Redirecting cytotoxic T lymphocyte responses with T-cell receptor transgenes

Expert Opinion on Biological Therapy

Volumn 2, Issue 4, 2002, Pages 353-360

  Clay, Timothy M ^a   Morse, Michael ^a   Lyerly, H Kim ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adoptive immunotherapy; Cytotoxic T cell; Gene transfer; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; CANCER; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENE TRANSFER; HUMAN; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; LYMPHOCYTE CLONE; MEDICAL RESEARCH; METASTASIS; NONHUMAN; REVIEW; T LYMPHOCYTE RECEPTOR GENE; TRANSGENE; VIRUS INFECTION;

ANIMALS; CLONING, MOLECULAR; GENE THERAPY; GENETIC VECTORS; HUMANS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; TRANSGENES;

EID: 0036249150     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2.4.353     Document Type: Review

References (51)

1. A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains
2. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins
3. T-cell antigen receptor genes and T-cell recognition
4. A direct estimate of the human αβ diversity
5. The human T-cell receptor TCRAC/TCRDC (C alpha/C delta) region: Organization, sequence, and evolution of 97.6 kb of DNA
6. Organization and sequences of diversity, joining, and constant region genes of the human T-cell receptor chain
7. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus
8. Transfer of specificity by murine alpha and beta T-cell receptor genes
9. Reconstitution of MHC Class I specificity by transfer of the T cell receptor and Lyt-2 genes
10. Specific antigen-Ia activation of transfected human T cells expressing murine Ti alpha/beta-human T3 receptor complexes
11. Predictable acquisition of a new MHC recognition specificity following expression of a transfected T-cell receptor beta-chain gene
12. Site-directed mutagenesis in the VDJ junctional region of a T cell receptor beta chain cause changes in antigenic peptide recognition
13. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen
14. Eradication of adenovirus El-induced tumors by E1A-specific cytotoxic T lymphocytes
15. Therapeutic use of a long-term T cell line recognizing a common tumor-associated antigen: The pattern of in vitro reactivity predicts the in vivo effect on different tumors
16. Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus Type 16- induced tumors
17. Improved in vivo efficiency of tumorinfiltrating lymphocytes after re-stimulation with irradiated tumor cells in vitro
18. Identification of a T-cell receptor from a therapeutic murine T-cell clone
19. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2
20. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
21. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
22. T cell receptor-MHC class I peptide interactions: Affinity, kinetics, and specificity
23. Studying interactions involving the T-cell antigen receptor by surface plasmon resonance
24. Interactions of TCRs with MHC-peptide complexes: A quantitative basis for mechanistic models
25. A kinetic window constricts the T cell receptor repertoire in the thymus
26. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity
27. Transfer of specificity for human immunodeficiency virus Type 1 into primary human T lymphocytes by introduction of T-cell receptor genes
28. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the αβ TCR complex
29. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer
30. Immunotherapy through TCR gene transfer
31. Specific cytotoxic T lymphocytes in gene therapy
32. The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways
33. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chain consisting of antibody-binding domains and gamma and zeta subunits of the immunoglobulin and the T-cell receptors
34. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain
35. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes
36. Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors
37. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells
38. T cell targeting of TAG72+ tumor cellsby a chimeric receptor with antibody-like specificity for a carbohydrate epitope
39. Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity
40. Anti-tumor activity of human T cells expressing the cc49-zeta chimeric immune receptor
41. A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-gamma chain chimeric receptor gene recognizing a human ovarian cancer antigen
42. Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells
43. Prolonged survival and tissue trafficking following adoptive transfer of CD4 zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects
44. Ligand recognition by alpha-beta T cell receptors
45. Partially phosphorylated T cell receptor zeta molecules can inhibit T cell activation
46. Karjalainen K Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes
47. Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes
48. Chimeric Fv-zeta or Fvepsilon receptors are not sufficient to induce activation or cytokine production in peripheral T cells
49. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR
50. Pharmacological control of antigen responsiveness in genetically modified T lymphocytes
51. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens